1xbet 모바일

Pharmaceuticals

March 11, 2010

Rapid Assay Kit 1xbet 모바일 RS virus, QUICKNAVI^™-RSV, Launch on April 6

1xbet 모바일 (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it shall launch the RS virus detection kit, QUICKNAVI^™-RSV, an in-vitro diagnostic kit on April 6.

Latest Pharmaceutical Business related News Releases

30 SEP 2024

HemeSight^®, the First-in-Japan Comprehensive Genomic Profiling Assay 1xbet 모바일 Hematological Malignancies, Receives Its First Regulatory Approval - HemeSight^®hematological malignancies gene panel test approved in Japan -

24 SEP 2024

1xbet 모바일 Obtains Additional Indication for Rexulti^®in Japan as an Adjunctive Treatment 1xbet 모바일 Agitation Associated with Dementia due to Alzheimer's Disease

1xbet 보너스 코드

1xbet 모바일 Receives Approval in Japan for Lupkynis^®as a Treatment 1xbet 모바일 Lupus Nephritis

News Releases | Otsuka

1xbet 모바일

Rapid Assay Kit 1xbet 모바일 RS virus, QUICKNAVI™-RSV, Launch on April 6

HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay 1xbet 모바일 Hematological Malignancies, Receives Its First Regulatory Approval - HemeSight®hematological malignancies gene panel test approved in Japan -

1xbet 모바일 Obtains Additional Indication for Rexulti®in Japan as an Adjunctive Treatment 1xbet 모바일 Agitation Associated with Dementia due to Alzheimer's Disease

1xbet 모바일 Receives Approval in Japan for Lupkynis®as a Treatment 1xbet 모바일 Lupus Nephritis

Rapid Assay Kit 1xbet 모바일 RS virus, QUICKNAVI^™-RSV, Launch on April 6

HemeSight^®, the First-in-Japan Comprehensive Genomic Profiling Assay 1xbet 모바일 Hematological Malignancies, Receives Its First Regulatory Approval - HemeSight^®hematological malignancies gene panel test approved in Japan -

1xbet 모바일 Obtains Additional Indication for Rexulti^®in Japan as an Adjunctive Treatment 1xbet 모바일 Agitation Associated with Dementia due to Alzheimer's Disease

1xbet 모바일 Receives Approval in Japan for Lupkynis^®as a Treatment 1xbet 모바일 Lupus Nephritis